vcfirmsdirectory.com

Venture capital

Curie.Bio

Curie.Bio is a venture firm for drug discovery that funds founders developing new therapeutics and supplies a large in-house group of experienced scientists and operators alongside the capital.

CambridgeRegistered · Cambridge
New investments · 12 months
Fund vehiclesPublic
5
5 active · US private fund
First chequePublic
$5M–$15M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:09 CETSources: curie.bio · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Curie.Bio joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Curie.Bio right for your round?

Is Curie.Bio a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
5
5 active · US private fund
SEC adviser filings
First chequePublic
$5M–$15M
From the firm’s website
curie.bio
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

CURIE BIO SERIES A FUND I, L.P.US private fund · Active · United States · $379.1M gross assets · filed 20 Mar 2026
CURIE BIO SEED FUND II, L.P.US private fund · Active · United States · $332.2M gross assets · filed 20 Mar 2026
CURIE BIO SEED FUND I, L.P.US private fund · Active · United States · $278.9M gross assets · filed 20 Mar 2026
CURIE BIO SEED FUND II-A, L.P.US private fund · Active · United States · $5.7M gross assets · filed 20 Mar 2026
CURIE BIO SERIES A FUND I-A, L.P.US private fund · Active · United States · $3M gross assets · filed 20 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Curie.Bio joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Curie.Bio joined

Round sizes, Curie.Bio’s role and who invested alongside.

Round-by-round history is part of PRO

Portfolio and exits

Every company Curie.Bio backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Curie.Bio puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Curie.Bio

Events where Curie.Bio’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Curie.Bio’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

20 Mar 2026Fund filingForm ADV filed by CURIE BIO: 5 private funds, $998.9M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Curie.Bio is based in Cambridge, United States.

5 fund vehicles are on public registers (SEC adviser filings), including CURIE BIO SERIES A FUND I, L.P., CURIE BIO SEED FUND II, L.P. and CURIE BIO SEED FUND I, L.P.

Funds therapeutic programs at any modality from concept through the clinic via two vehicles: one for preclinical milestones and one for clinical proof of concept. Beyond money, it embeds experienced drug developers who plan R&D, run experiments, and help raise follow-on capital. From the firm’s own website.

$5M to $15M per investment, according to the firm’s own website.

Know before Curie.Bio’s next round is announced.

PRO tracks Curie.Bio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Curie.BioGet Curie.Bio’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.